We are live on ! Find out more
RFM

Royal Fund Management Portfolio holdings

AUM $1.2B
1-Year Est. Return 32.21%
This Fund
S&P 500
This Quarter Est. Return
+2.04%
1 Year Est. Return
+32.21%
3 Year Est. Return
+92.42%
5 Year Est. Return
+97.01%
10 Year Est. Return
–
AUM
$359M
AUM Growth
+$21.3M
Cap. Flow
+$16.7M
Cap. Flow %
4.66%
Top 10 Hldgs %
27.69%
Holding
711
New
115
Increased
178
Reduced
104
Closed
38

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$4.4M
2
UPS icon
United Parcel Service
UPS
+$4.14M
3
ELD icon
WisdomTree Emerging Markets Local Debt Fund
ELD
+$2.5M
4
JCI icon
Johnson Controls International
JCI
+$2.41M
5
ABBV icon
AbbVie
ABBV
+$1.97M

Top Sells

Rank Stock Value
1
SPYV icon
State Street SPDR Portfolio S&P 500 Value ETF
SPYV
+$3.54M
2
PFE icon
Pfizer
PFE
+$3.19M
3
WM icon
Waste Management
WM
+$3.18M
4
T icon
AT&T
T
+$2.83M
5
SPTL icon
State Street SPDR Portfolio Long Term Treasury ETF
SPTL
+$2.83M

Sector Composition

Rank Sector Weight
1 Technology 9.92%
2 Healthcare 8.24%
3 Consumer Staples 7.22%
4 Energy 6.62%
5 Consumer Discretionary 5.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MDLZ icon
526
Mondelez International
MDLZ
$79.5B
$2K ﹤0.01%
+50
New +$2.74K
MORT icon
527
VanEck Mortgage REIT Income ETF
MORT
$360M
$2K ﹤0.01%
100
– –
PLD icon
528
Prologis
PLD
$135B
$2K ﹤0.01%
+30
New +$2.48K
RIG icon
529
Transocean
RIG
$5.89B
$2K ﹤0.01%
457
– –
SAN icon
530
Banco Santander
SAN
$201B
$2K ﹤0.01%
608
– –
SHY icon
531
iShares 1-3 Year Treasury Bond ETF
SHY
$25.5B
$2K ﹤0.01%
+32
New +$2.71K
TEVA icon
532
Teva Pharmaceuticals
TEVA
$40.8B
$2K ﹤0.01%
+400
New +$3.06K
TRI icon
533
Thomson Reuters
TRI
$42.8B
$2K ﹤0.01%
+41
New +$2.91K
ULTA icon
534
Ulta Beauty
ULTA
$22B
$2K ﹤0.01%
+8
New +$2.46K
VTR icon
535
Ventas
VTR
$48B
$2K ﹤0.01%
+40
New +$2.84K
HEXO
536
DELISTED
HEXO Corp. Common Shares
HEXO
$2K ﹤0.01%
12
+5
+71% +$1.25K
TWTR
537
DELISTED
Twitter, Inc.
TWTR
$2K ﹤0.01%
62
-25
-29% -$1.02K
AMPE
538
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$2K ﹤0.01%
13
– –
GWPH
539
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$2K ﹤0.01%
20
– –
IID
540
DELISTED
VOYA INTERNATIONAL HIGH DIVIDEND EQUITY INCOME FUND
IID
$2K ﹤0.01%
500
– –
EE
541
DELISTED
El Paso Electric Company
EE
$2K ﹤0.01%
37
– –
ACWI icon
542
iShares MSCI ACWI ETF
ACWI
$32.5B
$1K ﹤0.01%
+14
New +$1.03K
AMD icon
543
Advanced Micro Devices
AMD
$776B
$1K ﹤0.01%
+55
New +$1.73K
AU icon
544
AngloGold Ashanti
AU
$40.1B
$1K ﹤0.01%
+100
New +$1.99K
AZO icon
545
AutoZone
AZO
$49.2B
$1K ﹤0.01%
1
– –
BHF icon
546
Brighthouse Financial
BHF
$3.56B
$1K ﹤0.01%
27
– –
DNL icon
547
WisdomTree Global ex-U.S. Quality Growth Fund
DNL
$481M
$1K ﹤0.01%
60
– –
DOV icon
548
Dover
DOV
$27.6B
$1K ﹤0.01%
19
– –
EA icon
549
Electronic Arts
EA
$53B
$1K ﹤0.01%
14
– –
ENZL icon
550
iShares MSCI New Zealand ETF
ENZL
$77.3M
$1K ﹤0.01%
28
– –
20 21
22
23 24

Similar funds

FCCPG
FountainVest China Capital Partners GP3 Grand Cayman, Cayman Islands $1.2B AUM 6.95% 1-Year Est. Return
AIM
Anchor Investment Management Columbia, South Carolina $1.2B AUM 17.33% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
CA
Callahan Advisors Houston, Texas $1.2B AUM 22.34% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
SGDR
SPX Gestao de Recursos Rio De Janeiro, Brazil $1.2B AUM 59.05% 1-Year Est. Return
CCM
Condor Capital Management Martinsville, New Jersey $1.2B AUM 13.18% 1-Year Est. Return
KOC
Koss-Olinger Consulting Gainesville, Florida $1.19B AUM 15.91% 1-Year Est. Return

Royal Fund Management's Q3 2019 Portfolio in Review

As of Q3 2019, Royal Fund Management held 711 positions worth $359M, up 6.3% from $337M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Royal Fund Management deployed $16.7M of net new capital in Q3 2019, opening 115 new positions and adding to 178 existing holdings. Its largest new stake was US Bancorp: 23,398 shares worth $1.29M.

By sector, the portfolio is most concentrated in Technology at 9.9% of assets, up from 9.8% a quarter earlier, followed by Healthcare and Consumer Staples.

On the sell side, the largest reduction was State Street SPDR Portfolio S&P 500 Value ETF, an estimated $3.54M trimmed.

  • Royal Fund Management's largest Q3 2019 buy was US Bancorp: 23,398 shares worth $1.29M.
  • Royal Fund Management added most to Bristol-Myers Squibb in Q3 2019, an estimated $4.4M increase.
  • Royal Fund Management's biggest Q3 2019 reduction was State Street SPDR Portfolio S&P 500 Value ETF, cutting an estimated $3.54M.
  • Royal Fund Management fully exited Kraft Heinz in Q3 2019, selling an estimated $755K.
  • Royal Fund Management's ten largest holdings make up 28% of its $359M portfolio in Q3 2019.
  • Royal Fund Management opened 115 new positions and closed 38 in Q3 2019.
  • Royal Fund Management's portfolio value rose 6.3% quarter-over-quarter to $359M.

Based on Royal Fund Management's 13F filing for Q3 2019, filed 8 May 2020.